| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8780633 | Gynecologic Oncology | 2018 | 6 Pages |
Abstract
The absence of ascites, a low CA-125, stage, and R0 at the time of cytoreduction are factors associated with LTS when controlling for other confounders. An extensively annotated clinicopathologic prediction model for LTS fell short of clinical utility suggesting that prognostic molecular profiles are needed to better predict which patients are likely to be long-term survivors.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
C.A. Hamilton, A. Miller, Y. Casablanca, N.S. Horowitz, B. Rungruang, T.C. Krivak, S.D. Richard, N. Rodriguez, M.J. Birrer, F.J. Backes, M.A. Geller, M. Quinn, M.J. Goodheart, D.G. Mutch, J.J. Kavanagh, G.L. Maxwell, M.A. Bookman,